-
ICICI Pru Life
511.95 706.50(%) -
HDFC Bank
729.65 1,020.35(%) -
Apollo Hospitals
8,925.00 9,326.80(%) -
Wework India
700.00 419.60(%) -
LG Electronics
1,736.35 1,736.40(%) -
Gland Pharma
3,039.00 3,039.00(%) -
Bharti Airtel
2,005.65 2,174.70(%) -
Leap India
143.10 143.10(%) -
Blue Star
1,497.00 1,450.00(%) -
Cupid
288.00 32.76(%) -
Netweb Technol.
4,995.00 2,037.65(%) -
Honasa Consumer
509.90 509.90(%) -
Manorama Indust.
1,867.00 1,867.00(%) -
Vodafone Idea
14.17 15.35(%) -
Technocraft Ven.
334.60 334.60(%) -
Bharat Dynamics
1,420.00 1,655.25(%) -
Dixon Technolog.
14,210.00 18,471.50(%) -
Billionbrains
194.60 112.02(%) -
Infosys
1,159.00 984.00(%) -
Gujarat Fluoroch
4,897.00 4,959.45(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Aurobindo Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 4666.0
- ISIN : INE406A01037
-
Today’s Low
1,621.90 -
Today’s High
1,670.00
-
Open
1,662.40 -
Perv Close
1,663.40 -
52W Low
1,016.10 -
52W High
1,682.40
Key Indicators
-
P/E(TTM)
36.96
-
Mar.Cap (₹Cr.)
94,211.83
-
Div & Yield %
0.24
-
Book Value(₹)
391.14
-
Debt-Equity Ratio
-2.48
-
AGM Date
14-Aug-2026
-
EPS
44.86
-
P/E Ratio
36.96
Financials Ratios
-
Debt-Equity Ratio
0.21
-
Mar.Cap (₹Cr.)
94,211.83
-
RONW (%)
11.18
-
ROCE (%)
13.51
Score Board
-
Equity (₹ in Cr.)
58.08
-
BV (₹)
391.10
-
Sales( ₹ in Cr.)
11,171.72
-
NP (in Cr.)
2,426.73
-
NP Var(%)
40.0
-
Div%
400.0
-
CPS (₹)
46.70
-
EPS (₹)
41.80
-
Traded Value (₹ in Lakhs)
96,215.60
-
52 Week High
1,682.40
-
52 Week Low
1,016.10
-
Price BSE
1657.0
-
Price NSE
1,663.00
-
Market Capital( in Cr.)
96,215.60
-
P/C Ratio
35.50
-
P/E Ratio
39.70
-
Price Vs.BV
41.80
-
13-Aug-2026( 06:02)
Corporate News - Aurob... - Aurobindo Pharma Limited has i...
-
05-Aug-2026( 10:04)
Corporate News - Aurob... - Aurobindo Pharma Limited (NSE:...
-
05-Aug-2026( 10:02)
Corporate News - Aurob... - Aurobindo Pharma Ltd. announce...
-
05-Aug-2026( 09:58)
Results - Announcements - Aurob... - Aurobindo Pharma Ltd share pri...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 11,171.72 | 10,933.30 | 10,645.64 | 8,457.00 | 11,287.14 | 15,823.68 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 11,171.72 | 10,933.30 | 10,645.64 | 8,457.00 | 11,287.14 | 15,823.68 |
| Other Income | 587.53 | 328.12 | 670.10 | 443.92 | 670.99 | 589.86 |
| Stock Adjustments | -46.55 | 67.66 | 116.23 | 263.95 | -45.51 | -2.99 |
| Total Income | 11,712.70 | 11,329.08 | 11,431.97 | 9,164.87 | 11,912.62 | 16,410.55 |
| EXPENDITURE : | ||||||
| Raw Materials | 5,311.58 | 5,675.34 | 5,964.48 | 4,755.95 | 5,800.74 | 7,241.83 |
| Power and Fuel Cost | 174.82 | 185.59 | 191.58 | 167.86 | 477.99 | 512.34 |
| Employee Cost | 1,161.15 | 1,063.07 | 980.56 | 890.53 | 1,600.04 | 1,735.42 |
| Other Manufacturing Expenses | 421.52 | 426.63 | 414.51 | 328.42 | 705.68 | 925.86 |
| Selling and Administration Expenses | 873.42 | 960.27 | 822.21 | 939.38 | 1,009.36 | 1,069.84 |
| Miscellaneous Expenses | 108.12 | 132.49 | 164.49 | 148.96 | 249.13 | 215.57 |
| Employee Benefit Expenses | 1,161.15 | 1,063.07 | 980.56 | 890.53 | 1,600.04 | 1,735.42 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 8,050.61 | 8,443.39 | 8,537.83 | 7,231.10 | 9,842.94 | 11,700.86 |
| Operating Profit | 3,662.09 | 2,885.69 | 2,894.14 | 1,933.77 | 2,069.68 | 4,709.69 |
| Interest | 213.15 | 230.04 | 182.60 | 74.58 | 16.94 | 28.68 |
| Gross Profit | 3,448.94 | 2,655.65 | 2,711.54 | 1,859.19 | 2,052.74 | 4,681.01 |
| Depreciation | 285.36 | 297.20 | 254.58 | 243.26 | 415.26 | 488.00 |
| Profit Before Tax | 3,163.58 | 2,358.45 | 2,456.96 | 1,615.93 | 1,637.48 | 4,193.01 |
| Current Tax | 746.82 | 627.37 | 598.08 | 412.16 | 379.70 | 1,043.34 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.96 | -15.71 | -95.26 | -23.34 | -196.93 | 36.76 |
| Reported Net Profit | 2,414.80 | 1,746.79 | 1,954.14 | 1,227.11 | 1,454.71 | 3,112.91 |
| Extraordinary Items | -11.93 | 9.46 | 3.28 | 9.94 | -81.27 | -0.13 |
| Adjusted Net Profit | 2,426.73 | 1,737.33 | 1,950.86 | 1,217.17 | 1,535.98 | 3,113.04 |
| Adjustment below Net Profit | 1.08 | -5.26 | -1.69 | 8.28 | 1.69 | -6.42 |
| P & L Balance brought forward | 20,090.40 | 18,348.87 | 16,660.08 | 15,864.14 | 14,671.41 | 11,799.30 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 232.30 | 0.00 | 263.66 | 439.45 | 263.67 | 234.38 |
| P & L Balance carried down | 22,273.98 | 20,090.40 | 18,348.87 | 16,660.08 | 15,864.14 | 14,671.41 |
| Dividend | 232.30 | 0.00 | 263.66 | 439.45 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 400.00 | 0.00 | 450.00 | 750.00 | 900.00 | 400.00 |
| Dividend Per Share(Rs) | 4.00 | 0.00 | 4.50 | 7.50 | 9.00 | 4.00 |
| Earnings Per Share-Unit Curr | 41.58 | 30.08 | 33.35 | 20.94 | 24.83 | 53.13 |
| Earnings Per Share(Adj)-Unit Curr | 41.58 | 30.08 | 33.35 | 20.94 | 24.83 | 53.13 |
| Book Value | 391.14 | 353.55 | 336.62 | 307.80 | 292.15 | 271.80 |
| Book Value(Adj)-Unit Curr | 391.14 | 353.55 | 336.62 | 307.80 | 292.15 | 271.80 |
